CASI · Categories · 8-K
CASI - SEC Form 8-K filings
CASI Pharmaceuticals Inc. (CASI) sec form 8-k filings - real-time wire coverage filtered to 8-K only.
Recent 8-K for CASI
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc (DE) (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- SEC Form 8-K filed by CASI Pharmaceuticals, Inc.8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits (Amendment)8-K/A - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Leadership Update8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- CASI Pharmaceuticals, Inc. filed SEC Form 8-K: Results Of Operations And Financial Condition, Financial Statements And Exhibits8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- SEC Form 8-K filed by CASI Pharmaceuticals, Inc.8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- SEC Form 8-K filed by CASI Pharmaceuticals, Inc.8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)
- SEC Form 8-K filed by CASI Pharmaceuticals, Inc.8-K - CASI Pharmaceuticals, Inc. (0000895051) (Filer)